NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Vestibular Schwannoma


Return to Library

Free Vestibular Schwannoma Articles


Research results from University of Toronto update knowledge of vestibular schwannoma



2009 JUN 22 - (NewsRx.com) -- "We describe a novel technique of cranioplasty using a vascularized mastoid bone flap in patients after translabyrinthine excision of vestibular schwannomas (VS). Postoperative outcomes in terms of pinna and postauricular deformity are evaluated. Retrospective study," scientists writing in the journal Skull Base - an Interdisciplinary Approach report.

"Tertiary referral center. Seventeen patients underwent cranioplasty with bone flap after translabyrinthine VS excision. At minimum follow-up of 12 months, none had a cerebrospinal fluid (CSF) leak. The measured pinna projections between the operated and non-operated sides had a mean difference of 0.80 mm (+/- 1.70), which is not statistically significant (p > 0.05). The mean depth of the postauricular depressions was 1.38 mm (+/- 0.93). Over the same period, 10 patients underwent translabyrinthine VS surgery without cranioplasty. In this group, there was a significant difference of 4.71 mm (+/- 1.53) in mean pinna underprojections on the operated sides compared with the non-operated sides. Compared with patients who have undergone cranioplasty, the retroauricular depressions were significantly deeper (p < 0.05) with a mean depth of 2.92 mm (+/- 1.21)," wrote H.W. Yuen and colleagues, University of Toronto.

The researchers concluded: "Vascularized mastoid cortical bone flap cranioplasty is a simple and effective technique to ameliorate the pinna and retroauricular deformities after translabyrinthine VS excision without increased surgical cost or the use of alloplastic materials."

Yuen and colleagues published their study in Skull Base - an Interdisciplinary Approach (Vascularized Mastoid Bone Flap Cranioplasty after Translabyrinthine Vestibular Schwannoma Surgery. Skull Base - an Interdisciplinary Approach, 2009;19(3):193-201).

Additional information can be obtained by contacting J.M. Chen, University of Toronto, Sunnybrook Health Science Center, Dept. of Otolaryngology Head & Neck Surgery, 2075 Bayview Avenue, M1-102, Toronto, ON M4N 3M5, Canada.

The publisher of the journal Skull Base - an Interdisciplinary Approach can be contacted at: Thieme Medical Publ Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Keywords: Canada, Toronto, Bone, Neurilemmoma, Oncology, Surgery, Vestibular Schwannoma, University of Toronto.

This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login